Key points are not available for this paper at this time.
The performance of a given comorbidity measure depends on the patient group and outcome. In general, the Elixhauser index seems the best so far, particularly for mortality beyond 30 days, although several newer, more inclusive measures are promising.
Sharabiani et al. (Tue,) studied this question.